News & Events

June 19, 2019

IntegriChain Named a 2019 Best Place to Work by Philadelphia Business Journal

Philadelphia, PA, June 19, 2019 – IntegriChain, a leading life sciences commercial data and analytics company that helps patients start therapy faster and stay on therapy longer, today announced that the Company has been named one of the Philadelphia Business Journal’s “Best Places to Work” for 2019 in the large-sized company category.

“We are proud of every single person on the IntegriChain team for creating a culture worthy of recognition by Philadelphia Business Journal as a Best Place to Work,” said IntegriChain CEO Kevin Leininger. “We are a collective force of really smart data scientists, engineers, and business professionals – driven by a passion to help patients start therapy faster and stay on therapy longer. We’ve experienced rapid growth over the past few years, now topping 200 team members with more to come. Yet we remain a tightly knit team of driven professionals who want to use data and technology to do good in the world and to make a difference in US healthcare. This joint mission, our commitment to Philly’s data tech scene, and a fun, casual work environment make IntegriChain a Best Place to Work.”

The Philadelphia Business Journal names companies to its “Best Places to Work” list using a rigorous scientific process based on responses to an independent employee engagement survey conducted by Quantum Workplace. As a finalist, IntegriChain’s culture was favorably ranked by employees in areas including work environment, people, personal growth, and professional development.

About IntegriChain
IntegriChain is a life sciences commercial data and analytics company that helps innovative bio/pharma manufacturers identify and remove barriers to patient therapy initiation and adherence. Our mission is to help all stakeholders in pharmaceutical access save as many patient days of therapy as possible. Our data-science-driven ICyte Platform and solutions uniquely focus on access challenges after the patient and provider commit to therapy. More than 165 life science manufacturers rely on insights delivered from IntegriChain’s data, analytics, and managed services to drive strategic decision-making and on-going business management across their payers, specialty pharmacies, patient services, and distribution channel partners. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Atlanta, GA, and Pune, India. For more information, visit www.integrichain.com and our blog, or follow us on Twitter @IntegriChain and LinkedIn.

Contact
Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand